Midlife changes in Alzheimer’s biomarkers may predict dementia
Studying brain scans and cerebrospinal fluid of healthy
adults, scientists have shown that changes in key markers of
Alzheimer’s disease during midlife may help identify those who will
develop dementia years later, according to new research.
Biomarkers of cell death in Alzheimer’s reverse course after symptom onset
Three promising biomarkers being studied to detect Alzheimer’s disease in its early stages appear to undergo a surprising shift as patients develop symptoms of dementia, researchers led by Anne Fagan, PhD, at the School of Medicine report.